| abstract |
The present disclosure provides methods, systems, compositions, and kits that address the microbiome-related therapeutic needs of health conditions and diseases. In particular, the present disclosure provides methods of treating a metabolic condition with a microbial composition, the method comprising: administering a therapeutically effective amount of a pharmaceutical composition comprising a population of isolated and purified microorganisms, wherein at least one of said microorganisms comprises a microorganism capable of producing butyric acid. |